This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2014 Remove Leads Remove Medical science
article thumbnail

Targeted therapies for chronic lymphocytic leukaemia in an evolving treatment landscape

European Pharmaceutical Review

AUGUST 15, 2024

1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. About the author Dr Mehrdad Mobasher, MPH, is the Chief Medical Officer for Hematology at BeiGene.

Safety 52
Safety Patients Medical Medicine 52
article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

FEBRUARY 22, 2023

Although effective, the inconvenience of regular injections can lead to poor patient adherence, with studies showing that persistence and adherence are generally better for oral medications compared with injections. He earned a BA in Computer Science from the University of California, Santa Cruz.

Food and Drug Administration 105
Food and Drug Administration Manufacturing Safety Pharmaceutical 105
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024